Jundishapur Journal of Microbiology

Published by: Kowsar

Extremely Low Prevalence of Erythromycin-Resistant Streptococcus pyogenes Isolates and Their Molecular Characteristics by M Protein Gene and Multilocus Sequence Typing Methods

Hauwa Mohammed Kalgo 1 , Azmiza Syawani Jasni 1 , Siti Rohani Abdul Hadi 2 , Nurul Huda Umar 3 , Siti Nur Adila Hamzah 1 and Rukman Awang Hamat 1 , *
Authors Information
1 Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM, Serdang, Malaysia
2 Microbiology Laboratory, Pathology Department, Hospital Serdang, 43400 Serdang, Malaysia
3 Pathology Department, Hospital Kuala Lumpur, Jalan Pahang, 50586, Wilayah Persekutuan, Kuala Lumpur, Malaysia
Article information
  • Jundishapur Journal of Microbiology: May 2018, 11 (5); e12779
  • Published Online: May 16, 2018
  • Article Type: Research Article
  • Received: May 8, 2017
  • Revised: February 26, 2018
  • Accepted: February 26, 2018
  • DOI: 10.5812/jjm.12779

To Cite: Mohammed Kalgo H, Syawani Jasni A, Rohani Abdul Hadi S, Huda Umar N, Nur Adila Hamzah S, et al. Extremely Low Prevalence of Erythromycin-Resistant Streptococcus pyogenes Isolates and Their Molecular Characteristics by M Protein Gene and Multilocus Sequence Typing Methods, Jundishapur J Microbiol. 2018 ; 11(5):e12779. doi: 10.5812/jjm.12779.

Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
  • 1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-94. doi: 10.1016/S1473-3099(05)70267-X. [PubMed: 16253886].
  • 2. Fittipaldi N, Beres SB, Olsen RJ, Kapur V, Shea PR, Watkins ME, et al. Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. Am J Pathol. 2012;180(4):1522-34. doi: 10.1016/j.ajpath.2011.12.037. [PubMed: 22330677].
  • 3. Gracia M, Diaz C, Coronel P, Gimeno M, Garcia-Rodas R, Rodriguez-Cerrato V, et al. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Diagn Microbiol Infect Dis. 2009;64(1):52-6. doi: 10.1016/j.diagmicrobio.2008.12.018. [PubMed: 19232860].
  • 4. Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, et al. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother. 2010;65(4):634-43. doi: 10.1093/jac/dkq006. [PubMed: 20118164].
  • 5. Huang CY, Lai JF, Huang IW, Chen PC, Wang HY, Shiau YR, et al. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan. J Clin Microbiol. 2014;52(2):508-16. doi: 10.1128/JCM.02383-13. [PubMed: 24478481]. [PubMed Central: PMC3911310].
  • 6. Liang Y, Liu X, Chang H, Ji L, Huang G, Fu Z, et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. J Med Microbiol. 2012;61(Pt 7):975-83. doi: 10.1099/jmm.0.042309-0. [PubMed: 22442290].
  • 7. Kaplan EL, Johnson DR, Nanthapisud P, Sirilertpanrana S, Chumdermpadetsuk S. A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications. Bull World Health Organ. 1992;70(4):433-7. [PubMed: 1394774]. [PubMed Central: PMC2393384].
  • 8. Jamal F, Pit S, Johnson DR, Kaplan EL. Characterization of group A streptococci isolated in Kuala Lumpur, Malaysia. J Trop Med Hyg. 1995;98(5):343-6. [PubMed: 7563264].
  • 9. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34(4):953-8. [PubMed: 8815115]. [PubMed Central: PMC228924].
  • 10. Friaes A, Lopes JP, Melo-Cristino J, Ramirez M, Portuguese Group for the Study of Streptococcal I. Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition. Int J Med Microbiol. 2013;303(8):505-13. doi: 10.1016/j.ijmm.2013.07.004. [PubMed: 23932912].
  • 11. Silva-Costa C, Friaes A, Ramirez M, Melo-Cristino J, Portuguese Group for the Study of Streptococcal I. Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption. Antimicrob Agents Chemother. 2012;56(11):5661-6. doi: 10.1128/AAC.01133-12. [PubMed: 22908153]. [PubMed Central: PMC3486545].
  • 12. Chan MS, Maiden MC, Spratt BG. Database-driven multi locus sequence typing (MLST) of bacterial pathogens. Bioinformatics. 2001;17(11):1077-83. [PubMed: 11724739].
  • 13. Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G, et al. emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years? J Clin Microbiol. 2007;45(7):2249-56. doi: 10.1128/JCM.00513-07. [PubMed: 17494723]. [PubMed Central: PMC1933002].
  • 14. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. Wayne: PA, USACLSI; 2013.
  • 15. Morosini MI, Baquero MR, Sanchez-Romero JM, Negri MC, Galan JC, del Campo R, et al. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother. 2003;47(4):1464-7. [PubMed: 12654695]. [PubMed Central: PMC152530].
  • 16. McGregor KF, Spratt BG, Kalia A, Bennett A, Bilek N, Beall B, et al. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol. 2004;186(13):4285-94. doi: 10.1128/JB.186.13.4285-4294.2004. [PubMed: 15205431]. [PubMed Central: PMC421626].
  • 17. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun. 2001;69(4):2416-27. doi: 10.1128/IAI.69.4.2416-2427.2001. [PubMed: 11254602]. [PubMed Central: PMC98174].
  • 18. Chang H, Shen X, Fu Z, Liu L, Shen Y, Liu X, et al. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Scand J Infect Dis. 2010;42(2):84-9. doi: 10.3109/00365540903321598. [PubMed: 19883153].
  • 19. Ikebe T, Hirasawa K, Suzuki R, Isobe J, Tanaka D, Katsukawa C, et al. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Antimicrob Agents Chemother. 2005;49(2):788-90. doi: 10.1128/AAC.49.2.788-790.2005. [PubMed: 15673769]. [PubMed Central: PMC547282].
  • 20. Silva-Costa C, Friaes A, Ramirez M, Melo-Cristino J. Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Rev Anti Infect Ther. 2015;13(5):615-28. doi: 10.1586/14787210.2015.1023292. [PubMed: 25746210].
  • 21. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337(7):441-6. doi: 10.1056/NEJM199708143370701. [PubMed: 9250845].
  • 22. Areas GP, Schuab RB, Neves FP, Barros RR. Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil. Mem Inst Oswaldo Cruz. 2014;109(7):935-9. [PubMed: 25410998]. [PubMed Central: PMC4296499].
  • 23. Montes M, Tamayo E, Mojica C, Garcia-Arenzana JM, Esnal O, Perez-Trallero E. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012. J Antimicrob Chemother. 2014;69(6):1474-82. doi: 10.1093/jac/dku039. [PubMed: 24562616].
  • 24. Hraoui M, Boutiba-Ben Boubaker I, Doloy A, Samir E, Ben Redjeb S, Bouvet A. Epidemiological markers of Streptococcus pyogenes strains in Tunisia. Clin Microbiol Infect. 2011;17(1):63-8. doi: 10.1111/j.1469-0691.2010.03174.x. [PubMed: 20132259].
  • 25. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1995;1(3):69-78. doi: 10.3201/eid0103.950301. [PubMed: 8903167]. [PubMed Central: PMC2626872].
  • 26. Chang H, Shen X, Huang G, Fu Z, Zheng Y, Wang L, et al. Molecular analysis of Streptococcus pyogenes strains isolated from Chinese children with pharyngitis. Diagn Microbiol Infect Dis. 2011;69(2):117-22. doi: 10.1016/j.diagmicrobio.2010.09.011. [PubMed: 21251553].
  • 27. Dhakal R, Sujatha S, Parija SC, Bhat BV. Asymptomatic colonization of upper respiratory tract by potential bacterial pathogens. Indian J Pediatr. 2010;77(7):775-8. doi: 10.1007/s12098-010-0118-x. [PubMed: 20589463].
  • 28. Brenciani A, Bacciaglia A, Vecchi M, Vitali LA, Varaldo PE, Giovanetti E. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob Agents Chemother. 2007;51(4):1209-16. doi: 10.1128/AAC.01484-06. [PubMed: 17261630]. [PubMed Central: PMC1855496].
  • 29. Alfaresi MS. Group A streptococcal genotypes from throat and skin isolates in the United Arab Emirates. BMC Res Notes. 2010;3:94. doi: 10.1186/1756-0500-3-94. [PubMed: 20370898]. [PubMed Central: PMC2907864].
  • 30. Dundar D, Sayan M, Tamer GS. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients. Microb Drug Resist. 2010;16(4):279-84. doi: 10.1089/mdr.2010.0021. [PubMed: 20624096]. [PubMed Central: PMC3124751].
  • 31. Green MD, Beall B, Marcon MJ, Allen CH, Bradley JS, Dashefsky B, et al. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother. 2006;57(6):1240-3. doi: 10.1093/jac/dkl101. [PubMed: 16556634].
  • 32. Zampaloni C, Cappelletti P, Prenna M, Vitali LA, Ripa S. emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol. 2003;41(3):1307-10. [PubMed: 12624074]. [PubMed Central: PMC150311].
  • 33. Bessen DE, McGregor KF, Whatmore AM. Relationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes. BMC Microbiol. 2008;8:59. doi: 10.1186/1471-2180-8-59. [PubMed: 18405369]. [PubMed Central: PMC2359762].
  • 34. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;9(10):611-6. doi: 10.1016/S1473-3099(09)70178-1. [PubMed: 19778763].
  • 35. McGregor KF, Spratt BG. Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J Clin Microbiol. 2005;43(4):1963-7. doi: 10.1128/JCM.43.4.1963-1967.2005. [PubMed: 15815033]. [PubMed Central: PMC1081391].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments